The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) is announcing a scientific meeting regarding peripheral nerve blockade. The purpose of this public workshop is to provide a forum to discuss the current state of knowledge regarding peripheral nerve blockade. Discussion will focus on the use of technology to facilitate performance of nerve blocks, therapeutic targets for peripheral nerve blockade, dose and duration of commonly used local anesthetics, use of adjuvant medications, and continuous infusions via peripheral nerve catheters.
Date: September 18, 2017
Time: 8:30 a.m to 5:00 p.m.
Location: Marriott Residence Inn Bethesda Downtown, 7335 Wisconsin Avenue, Bethesda, MD 20814
Registration: To register for this public workshop, please email your registration to Allison.Meyer@fda.hhs.gov by September 11, 2017 midnight Eastern Standard Time. Please provide complete contact information for each attendee, including name, title, affiliation, address, email, and telephone. Those without email access may register by contacting Allison Meyer at 301–796–1258. There is no registration fee to attend this public workshop. Early registration is recommended because seating is limited. Registration will be on a first-come, first-served basis. If time and space permit, onsite registration on the day of the public workshop will be provided beginning at 8:00 a.m.
Contact information: Allison Meyer, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993–0002, 301–796–1258, email: Allison.Meyer@fda.hhs.gov.
Topics to be discussed include:
- Single-injection nerve blocks with plain local anesthetics and reformulations
- Localization techniques
- Multimodal perineural analgesia
- Perineural catheters
- Site considerations
- Patient size and patient age considerations
- Epidemiology of peripheral nerve blocks vs. general anesthesia
Other materials will be added once available.
Transcript: As soon as a transcript of the public workshop is available, it will be accessible at https://www.regulations.gov. It may be viewed at the Dockets Management Staff, (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. A link to the transcript will also be available under meeting materials above.